Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision label, v3.5.4, appears on the page, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s footer revision/version has been updated from **v3.5.0** to **v3.5.3**.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Small Cell Lung Carcinoma and Acute Myeloid Leukemia to the study conditions and introduced the Genetic and Rare Diseases Information Center as a new resources entry.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No study details or user-facing content appear to have changed.SummaryDifference0.0%

- Check108 days agoChange DetectedThe page now displays Revision: v3.4.2, updating from Revision: v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.